IL6 and head and neck squamous cell carcinoma: Increased radio- and chemoresistance, higher proliferation, elevated invasion, and metastatic potential as well as promoted epithelial-mesenchymal transition of hypoxic HNSCC could all contribute to the prognostic value of IL-6.